Literature DB >> 34389624

Differential Regulation of ATP- and UTP-Evoked Prostaglandin E2 and IL-6 Production from Human Airway Epithelial Cells.

Timothy S Kountz1, Amit Jairaman1, Candace D Kountz1, Kenneth A Stauderman2, Robert P Schleimer3, Murali Prakriya4,3.   

Abstract

The airway epithelial cells (AECs) lining the conducting passageways of the lung secrete a variety of immunomodulatory factors. Among these, PGE2 limits lung inflammation and promotes bronchodilation. By contrast, IL-6 drives intense airway inflammation, remodeling, and fibrosis. The signaling that differentiates the production of these opposing mediators is not understood. In this study, we find that the production of PGE2 and IL-6 following stimulation of human AECs by the damage-associated molecular pattern extracellular ATP shares a common requirement for Ca2+ release-activated Ca2+ (CRAC) channels. ATP-mediated synthesis of PGE2 required activation of metabotropic P2Y2 receptors and CRAC channel-mediated cytosolic phospholipase A2 signaling. By contrast, ATP-evoked synthesis of IL-6 occurred via activation of ionotropic P2X receptors and CRAC channel-mediated calcineurin/NFAT signaling. In contrast to ATP, which elicited the production of both PGE2 and IL-6, the uridine nucleotide, UTP, stimulated PGE2 but not IL-6 production. These results reveal that human AECs employ unique receptor-specific signaling mechanisms with CRAC channels as a signaling nexus to regulate release of opposing immunomodulatory mediators. Collectively, our results identify P2Y2 receptors, CRAC channels, and P2X receptors as potential intervention targets for airway diseases.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34389624      PMCID: PMC8816324          DOI: 10.4049/jimmunol.2100127

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  82 in total

1.  Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation.

Authors:  Md Ashik Ullah; Joana A Revez; Zhixuan Loh; Jennifer Simpson; Vivian Zhang; Lisa Bain; Antiopi Varelias; Stefan Rose-John; Antje Blumenthal; Mark J Smyth; Geoffrey R Hill; Maria B Sukkar; Manuel A R Ferreira; Simon Phipps
Journal:  J Allergy Clin Immunol       Date:  2015-04-28       Impact factor: 10.793

2.  ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation.

Authors:  Björn-Philipp Diercks; René Werner; Paula Weidemüller; Frederik Czarniak; Lola Hernandez; Cari Lehmann; Annette Rosche; Aileen Krüger; Ulrike Kaufmann; Martin Vaeth; Antonio V Failla; Bernd Zobiak; Farid I Kandil; Daniel Schetelig; Alexandra Ruthenbeck; Chris Meier; Dmitri Lodygin; Alexander Flügel; Dejian Ren; Insa M A Wolf; Stefan Feske; Andreas H Guse
Journal:  Sci Signal       Date:  2018-12-18       Impact factor: 8.192

3.  Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis.

Authors:  Nicolas Riteau; Pamela Gasse; Louis Fauconnier; Aurélie Gombault; Marion Couegnat; Lizette Fick; Jean Kanellopoulos; Valérie F J Quesniaux; Sylvain Marchand-Adam; Bruno Crestani; Bernhard Ryffel; Isabelle Couillin
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

4.  Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation.

Authors:  E R Lazarowski; L Homolya; R C Boucher; T K Harden
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

Review 5.  Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.

Authors:  K F Chung
Journal:  Sci STKE       Date:  2005-09-27

6.  Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.

Authors:  J M Trevillyan; X G Chiou; Y W Chen; S J Ballaron; M P Sheets; M L Smith; P E Wiedeman; U Warrior; J Wilkins; E J Gubbins; G D Gagne; J Fagerland; G W Carter; J R Luly; K W Mollison; S W Djuric
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

Review 7.  Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides.

Authors:  C M Anderson; F E Parkinson
Journal:  Trends Pharmacol Sci       Date:  1997-10       Impact factor: 14.819

8.  Purinergic P2Y receptors in airway epithelia: from ion transport to immune functions.

Authors:  Yuan Hao; Wing-hung Ko
Journal:  Sheng Li Xue Bao       Date:  2014-02-25

9.  Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells.

Authors:  Wei-Chiao Chang; Charmaine Nelson; Anant B Parekh
Journal:  FASEB J       Date:  2006-10-03       Impact factor: 5.191

10.  Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.

Authors:  Joseph Miller; Charles Bruen; Michael Schnaus; Jeffrey Zhang; Sadia Ali; April Lind; Zachary Stoecker; Kenneth Stauderman; Sudarshan Hebbar
Journal:  Crit Care       Date:  2020-08-14       Impact factor: 9.097

View more
  3 in total

1.  Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I-Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells.

Authors:  Timothy S Kountz; Assel Biyasheva; Robert P Schleimer; Murali Prakriya
Journal:  J Immunol       Date:  2022-04-22       Impact factor: 5.426

Review 2.  Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis.

Authors:  Olivier Burgy; Sabrina Loriod; Guillaume Beltramo; Philippe Bonniaud
Journal:  Cells       Date:  2022-04-03       Impact factor: 6.600

3.  STIM1 is a core trigger of airway smooth muscle remodeling and hyperresponsiveness in asthma.

Authors:  Martin T Johnson; Ping Xin; J Cory Benson; Trayambak Pathak; Vonn Walter; Scott M Emrich; Ryan E Yoast; Xuexin Zhang; Gaoyuan Cao; Reynold A Panettieri; Mohamed Trebak
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.